News bites
EMA invites feedback
The EMA released two concept papers for a 3month public consultation that address the need to revise existing guidelines on
biosimilar medicines and influenza vaccines. Feedback can be submitted until 31 December 2011.
Read more at:
http://www.pharmtech.com/EMApapers
AstraZeneca in China
AstraZeneca is investing $200 million in a new manufacturing facility in China for intravenous and solid medicines. The facility
will be located in Taizhou, with construction due to finish at the end of 2013, and will help the company to expand its medicines
availability in urban and rural communities.
Read more at:
http://www.pharmtech.com/azinchina
GSK and fast cars
GSK has formed a long-term partnership with the UK-based McLaren Group, which is best known for its expertise in the Formula
1 motor sport. McLaren will share its capabilities in engineering, technology, analytics and strategy modelling to help improve
GSK's manufacturing, R&D and consumer-healthcare areas.
Read more at:
http://www.pharmtech.com/formula1
FDA enhances database
The FDA is considering whether to enhance its inspections database by adding specific search criteria that would both enhance
data analysis and make the system more user friendly. The idea was included in a list of eight draft proposals for increasing
transparency that the agency published in October.
Read more at:
http://www.pharmtech.com/fdasearch
Sign up for our weekly e-Alert at
http://www.pharmtech.com/signup
|
